35.67 Requirements H&S (a) A licensee in possession of for possession any sealed source or of sealed brachytherapy source shall follow sources and the radiation safety and handling brachytherapy instructions supplied by the sources manufacturer. (b) A licensee in possession of a sealed source shall- (1) Test the source for leakage before its first use unless the licensee has a certificate from the supplier indicating that the source was tested within 6 months before transfer to the licensee; and (2) Test the source for leakage at intervals not to exceed 6 months or at other intervals approved by the Commission or an in the Sealed Source and Device Registry. (c) To satisfy the leak test requirements of this section, the licensee shall measure the sample so that the leak test can detect the presence of 185 Bq (0.005 uCi) of radioactive material in the sample. 35.69 Labeling of H&S Each syringe and vial that vials and contains unsealed byproduct syringes material must be labeled to identify the radioactive drug. Each syringe shield and vial shield must
35.67 Requirements for possession of sealed sources and brachytherapy sources H&S (a) A licensee in possession of any sealed source or brachytherapy source shall follow the radiation safety and handling instructions supplied by the manufacturer. (b) A licensee in possession of a sealed source shall- (1) Test the source for leakage before its first use unless the licensee has a certificate from the supplier indicating that the source was tested within 6 months before transfer to the licensee; and (2) Test the source for leakage at intervals not to exceed 6 months or at other intervals approved by the Commission or an in the Sealed Source and Device Registry. (c) To satisfy the leak test requirements of this section, the licensee shall measure the sample so that the leak test can detect the presence of 185 Bq (0.005 uCi) of radioactive material in the sample. 35.69 Labeling of vials and syringes H&S Each syringe and vial that contains unsealed byproduct material must be labeled to identify the radioactive drug. Each syringe shield and vial shield must